Becton, Dickinson & Co. (BDX)
177.85
+1.43
(+0.81%)
USD |
NYSE |
Sep 11, 16:00
177.89
+0.04
(+0.02%)
After-Hours: 20:00
Becton, Dickinson Enterprise Value : 64.39B for Sept. 11, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 11, 2026 | 64.39B |
| September 10, 2026 | 64.00B |
| September 09, 2026 | 64.92B |
| September 08, 2026 | 64.73B |
| September 04, 2026 | 66.26B |
| September 03, 2026 | 67.05B |
| September 02, 2026 | 67.02B |
| September 01, 2026 | 66.91B |
| August 31, 2026 | 67.18B |
| August 28, 2026 | 67.57B |
| August 27, 2026 | 67.19B |
| August 26, 2026 | 67.75B |
| August 25, 2026 | 67.64B |
| August 24, 2026 | 67.90B |
| August 21, 2026 | 68.24B |
| August 20, 2026 | 67.05B |
| August 19, 2026 | 67.04B |
| August 18, 2026 | 65.18B |
| August 17, 2026 | 65.54B |
| August 14, 2026 | 65.90B |
| August 13, 2026 | 65.51B |
| August 12, 2026 | 65.95B |
| August 11, 2026 | 65.36B |
| August 10, 2026 | 64.87B |
| August 07, 2026 | 64.12B |
| Date | Value |
|---|---|
| August 06, 2026 | 64.18B |
| August 05, 2026 | 62.43B |
| August 04, 2026 | 62.28B |
| August 03, 2026 | 62.31B |
| July 31, 2026 | 61.06B |
| July 30, 2026 | 61.01B |
| July 29, 2026 | 61.81B |
| July 28, 2026 | 61.25B |
| July 27, 2026 | 59.23B |
| July 24, 2026 | 58.53B |
| July 23, 2026 | 57.61B |
| July 22, 2026 | 57.66B |
| July 21, 2026 | 57.85B |
| July 20, 2026 | 58.02B |
| July 17, 2026 | 59.03B |
| July 16, 2026 | 59.51B |
| July 15, 2026 | 58.13B |
| July 14, 2026 | 56.98B |
| July 13, 2026 | 57.85B |
| July 10, 2026 | 57.33B |
| July 09, 2026 | 57.03B |
| July 08, 2026 | 56.95B |
| July 07, 2026 | 58.52B |
| July 06, 2026 | 58.31B |
| July 02, 2026 | 59.00B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 204.07B |
| Boston Scientific Corp. | 74.40B |
| Stryker Corp. | 117.67B |
| Baxter International, Inc. | 18.98B |
| DexCom, Inc. | 30.79B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | 451.00M |
| Revenue (Quarterly) | 4.983B |
| Total Expenses (Quarterly) | 4.532B |
| EPS Diluted (Quarterly) | 1.370 |
| Gross Profit Margin (Quarterly) | 46.46% |
| Profit Margin (Quarterly) | 9.05% |
| Earnings Yield | 1.86% |
| Operating Earnings Yield | 6.04% |
| Normalized Earnings Yield | -1.391 |